Literature DB >> 10959685

Impact, diagnosis and treatment of von Willebrand disease.

J E Sadler1, P M Mannucci, E Berntorp, N Bochkov, V Boulyjenkov, D Ginsburg, D Meyer, I Peake, F Rodeghiero, A Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10959685

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  60 in total

1.  VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Authors:  Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Amy D Shapiro; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Jeanne M Lusher; Margaret V Ragni; Robert R Montgomery
Journal:  Blood       Date:  2011-12-23       Impact factor: 22.113

Review 2.  Von Willebrand disease in the United States: a perspective from Wisconsin.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Daniel B Bellissimo; Sandra L Haberichter; Robert R Montgomery
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

3.  Clinical utility gene card for: von Willebrand disease.

Authors:  Anthony M Cumming; Stephen Keeney; P Vincent Jenkins; Michael J Nash; James S O'Donnell
Journal:  Eur J Hum Genet       Date:  2011-01-05       Impact factor: 4.246

4.  The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.

Authors:  Sandra L Haberichter; Ulrich Budde; Tobias Obser; Sonja Schneppenheim; Cornelia Wermes; Reinhard Schneppenheim
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

5.  Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume.

Authors:  E Scharrer; H Hessel; A Kronseder; W Guth; B Rolinski; R A Jörres; K Radon; R Schierl; P Angerer; D Nowak
Journal:  Int Arch Occup Environ Health       Date:  2006-06-22       Impact factor: 3.015

6.  A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.

Authors:  Andrew Yee; Robert D Gildersleeve; Shufang Gu; Colin A Kretz; Beth M McGee; Keisha M Carr; Steven W Pipe; David Ginsburg
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

7.  The diagnosis and treatment of von Willebrand disease in children.

Authors:  Robert J Klaassen; Jacqueline M Halton
Journal:  Paediatr Child Health       Date:  2002-04       Impact factor: 2.253

Review 8.  The use of desmopressin in acquired haemophilia A: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

9.  Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Authors:  Sandra L Haberichter; Elizabeth P Merricks; Scot A Fahs; Pamela A Christopherson; Timothy C Nichols; Robert R Montgomery
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

10.  The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.

Authors:  Natalia Rydz; Laura L Swystun; Colleen Notley; Andrew D Paterson; J Jacob Riches; Kate Sponagle; Boonchai Boonyawat; Robert R Montgomery; Paula D James; David Lillicrap
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.